logo
Select company
Select metric
$ -4.04MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
30
Sector
70
Industry
38
History
89
$ 2.29Close
$ 1 - $ 2.65 52-Week Range
Ticker Information

Ticker

AYTU

Company Name

AYTU BIOPHARMA INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

AYTU BIOPHARMA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AYTU - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 5.38M$ -9.42M$ -4.04M
3/31/2025$ 6.03M$ 10.1M$ 16.13M
12/31/2024$ 6.63M$ 2.69M$ 9.31M
9/30/2024$ 7.47M$ 1.71M$ 9.18M
6/30/2024$ 8.27M$ -9.28M$ -1.01M
3/31/2024$ 8.44M$ -12.61M$ -4.17M
12/31/2023$ 8.72M$ -17.17M$ -8.45M
9/30/2023$ 8.72M$ -24.47M$ -15.75M
6/30/2023$ 8.81M$ -17.05M$ -8.24M
3/31/2023$ 8.95M$ -32.3M$ -23.35M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AYTU BIOPHARMA INC's latest trailing twelve months (TTM) EBITDA stands at $ -5.53M.
  • Over the past 5 years, AYTU BIOPHARMA INC's average EBITDA has been $ -31.11M.
  • The median EBITDA for AYTU BIOPHARMA INC during this period was $ -14.98M
  • AYTU BIOPHARMA INC reached its highest EBITDA over the past 5 years at $ 16.13M.
  • The lowest EBITDA recorded by AYTU BIOPHARMA INC in the same timeframe $ -104.42M

AYTU BIOPHARMA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
FLGC : FLORA GROWTH CORP $ -12.18MRMTI : ROCKWELL MEDICAL INC $ 3.34MADAP : ADAPTIMMUNE THERAPEUTICS PLC $ -149.75MCOSM : COSMOS HEALTH INC $ -12.84MIRIX : IRIDEX CORP $ -3.99MIMCC : IM CANNABIS CORP $ 5.04MBFRI : BIOFRONTERA INC $ -15.35MAPUS : APIMEDS PHARMACEUTICALS US INC $ -3.58MHBIO : HARVARD BIOSCIENCE INC $ -46.8MRVP : RETRACTABLE TECHNOLOGIES INC $ -829.42K

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for AYTU BIOPHARMA INC is calculated as follows: EBIT [ $ -13M ] + DepAmor [ $ 7.47M ]
(=) EBITDA [ $ -5.53M ]

AYTU - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -104.42M

Minimum

Mar 31, 2022

$ 16.13M

Maximum

Mar 31, 2025

$ -31.11M

Average

$ -14.98M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M